<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 11.8: Complex Case Synthesis & Protocol Customization</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - DEEP BLUE/GOLD theme for Capstone/Advanced Module */
        .module-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #1e3a8a;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e3a8a;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #eff6ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e40af;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e3a8a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #1e40af;
            margin: 30px 0 15px 0;
            font-weight: 600;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
            letter-spacing: 0.5px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #3b82f6, #1e3a8a);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            flex-shrink: 0;
            color: white;
        }

        /* Statistics Highlight */
        .stat-highlight {
            background: #f1f5f9;
            border-left: 4px solid #3b82f6;
            padding: 15px 20px;
            margin: 20px 0;
            font-weight: 500;
            color: #1e40af;
        }

        /* Data Table */
        .data-table-container {
            overflow-x: auto;
            margin: 30px 0;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            background: white;
        }

        th {
            background: #1e3a8a;
            color: white;
            text-align: left;
            padding: 12px 15px;
        }

        td {
            padding: 12px 15px;
            border-bottom: 1px solid #eee;
        }

        tr:nth-child(even) {
            background: #f9fafb;
        }

        /* Alert Boxes */
        .alert-box {
            padding: 26px 30px;
            margin: 35px 0;
            border-radius: 0 14px 14px 0;
            border-left: 5px solid;
        }

        .alert-box.warning {
            background: #fff8e6;
            border-left-color: #ff9800;
        }

        .alert-box.info {
            background: #e3f2fd;
            border-left-color: #2196f3;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .reveal-btn {
            background: #1e3a8a;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f0f8f0;
            border-radius: 8px;
            color: #2e7d32;
        }

        /* Key Takeaways */
        .takeaways-box {
            background: linear-gradient(135deg, #f5f5f5 0%, #e8e8e8 100%);
            padding: 25px;
            margin-top: 35px;
            border-radius: 12px;
            border: 1px solid #ddd;
        }

        .references-box {
            margin-top: 40px;
            padding: 25px;
            background: #fff;
            border: 1px solid #eee;
            border-radius: 12px;
            font-size: 14px;
        }

        .references-box h4 {
            margin-top: 0;
            color: #1e3a8a;
        }

        .references-box ul {
            padding-left: 20px;
            margin-bottom: 0;
        }

        .references-box li {
            margin-bottom: 8px;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            opacity: 0.9;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 11: L1 Deep Dive - Advanced Clinical Applications</p>
            <h1 class="lesson-title">Lesson 8: Complex Case Synthesis & Protocol Customization</h1>
            <div class="lesson-meta">
                <span class="meta-item">45 min read</span>
                <span class="meta-item">Lesson 8 of 8</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The Triad: T2D, NAFLD, & Thyroid</a></li>
                <li><a href="#section2"><span class="section-num">2</span>Advanced Troubleshooting Logic</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Architecture of Maintenance (E)</a></li>
                <li><a href="#section4"><span class="section-num">4</span>Clinical Decision-Making & Referrals</a></li>
                <li><a href="#section5"><span class="section-num">5</span>The Advanced Coach's Toolkit</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Capstone Case Study Synthesis</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Synthesize all S.T.A.B.L.E. pillars to manage clients with concurrent metabolic and endocrine pathologies.</li>
                <li>Identify the biochemical "logjams" that cause blood sugar stagnation despite high protocol adherence.</li>
                <li>Design a long-term "Empower & Sustain" plan targeting an HbA1c < 5.7% and metabolic flexibility.</li>
                <li>Master the professional boundaries of clinical collaboration and high-level medical reporting.</li>
                <li>Utilize advanced Continuous Glucose Monitor (CGM) analytics to drive precise lifestyle adjustments.</li>
            </ul>
        </div>

        <h2 id="section1">1. The Metabolic Triad: T2D, NAFLD, and Hypothyroidism</h2>
        <p>In clinical practice, you will rarely encounter a "clean" case of Type 2 Diabetes. More often, you are dealing with a <span class="highlight">multi-morbid matrix</span> where multiple systems are failing simultaneously. The most common triad is the intersection of insulin resistance, Non-Alcoholic Fatty Liver Disease (NAFLD), and Hypothyroidism.</p>
        
        <p>This triad creates a "metabolic trap." NAFLD impairs the liver's ability to sense insulin, leading to excessive <span class="highlight">gluconeogenesis</span> (sugar production) even during fasting. Simultaneously, hypothyroidism lowers the Basal Metabolic Rate (BMR) and reduces the expression of GLUT4 transporters in skeletal muscle, making the "Glucose Sink" we discussed in Module 3 significantly less efficient.</p>

        <div class="stat-highlight">
            A 2021 study published in <i>The Lancet Gastroenterology & Hepatology</i> (n=18,401) demonstrated that patients with NAFLD have a 2.19-fold increased risk of developing Type 2 Diabetes, while subclinical hypothyroidism further increases insulin resistance (HOMA-IR) by an average of 14.2%.
        </div>

        <p>When customizing a protocol for this triad, the S.T.A.B.L.E. Methodâ„¢ must be sequenced carefully:</p>
        <ul>
            <li><strong>S (Screen):</strong> Look for the TSH/fT3/fT4 ratio alongside ALT/AST and HOMA-IR.</li>
            <li><strong>T (Transform Nutrition):</strong> Prioritize <i>Choline</i> and <i>Methionine</i> to support hepatic lipid export while maintaining low glycemic load.</li>
            <li><strong>A (Activate Movement):</strong> Focus on Zone 2 aerobic work to stimulate mitochondrial biogenesis, which is often suppressed in hypothyroid states.</li>
        </ul>

        <h2 id="section2">2. Advanced Troubleshooting: Why Blood Sugar Remains High</h2>
        <p>It is the most frustrating scenario for both coach and client: the nutrition is "perfect," the exercise is consistent, sleep is 8 hours, and yet, the fasting glucose remains stuck at 115 mg/dL. As an AccrediPro specialist, you must look beyond the basics into <span class="highlight">secondary metabolic disruptors</span>.</p>

        <h3>The "Logjam" Checklist:</h3>
        <p>If a client is plateauing, investigate these three physiological barriers:</p>
        <ol>
            <li><strong>Hepatic Insulin Resistance:</strong> The liver is "deaf" to insulin signals. Even if the client eats zero carbs, the liver overproduces glucose via the Polyol pathway and gluconeogenesis.
                <br><i>Solution:</i> Increase the "B" (Balance) pillarâ€”specifically focusing on evening cortisol management to suppress nocturnal glucose production.</li>
            <li><strong>The "Dawn Phenomenon" vs. "Somogyi Effect":</strong> Use CGM data to determine if the morning spike is due to a natural cortisol surge (Dawn) or a rebound from a nocturnal hypoglycemic event (Somogyi).</li>
            <li><strong>Chronic Low-Grade Inflammation (CLGI):</strong> Elevated CRP or ferritin levels can keep the body in a state of "metabolic alarm," where cytokines like TNF-alpha directly interfere with the insulin signaling cascade.</li>
        </ol>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Barrier</th>
                        <th>Biomarker Clue</th>
                        <th>STABLE Intervention</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td>Hepatic Congestion</td>
                        <td>ALT > 25 U/L; AST/ALT ratio < 1</td>
                        <td><strong>T:</strong> Increase bitter greens/cruciferous; <strong>B:</strong> Milk Thistle/NAC</td>
                    </tr>
                    <tr>
                        <td>Mitochondrial Decay</td>
                        <td>Low fT3; Fatigue despite sleep</td>
                        <td><strong>A:</strong> Switch HIIT to heavy lifting; <strong>S:</strong> Check CoQ10/Mg</td>
                    </tr>
                    <li>Hidden Stressor</li>
                    <td>High AM Cortisol; Low HRV</td>
                    <td><strong>L:</strong> Circadian light hygiene; <strong>E:</strong> Vagus nerve stimulation</td>
                </tr>
                </tbody>
            </table>
        </div>

        <h2 id="section3">3. Architecture of Maintenance: The "E" Pillar (Empower & Sustain)</h2>
        <p>The goal of the Diabetes & Blood Sugar Coach is not just "remission" (A1c < 6.5% without meds), but <span class="highlight">metabolic optimization</span> (A1c < 5.7% with robust flexibility). Transitioning a client from the "Correction Phase" to the "Maintenance Phase" requires a shift in behavioral architecture.</p>

        <p>A 2023 meta-analysis of long-term diabetes interventions found that 70% of participants regain weight and lose glycemic control within 24 months due to "protocol fatigue." To prevent this, your <strong>Empower & Sustain (E)</strong> plan must include:</p>
        
        <ul>
            <li><strong>Metabolic Flexibility Testing:</strong> Gradually reintroducing higher-glycemic whole foods (e.g., berries, sweet potatoes) while monitoring the CGM for a 2-hour return to baseline (< 120 mg/dL).</li>
            <li><strong>The 80/20 Stability Rule:</strong> Establishing a "Metabolic Buffer" where 20% of meals can be off-protocol without triggering a multi-day inflammatory cascade.</li>
            <li><strong>Self-Correction Algorithms:</strong> Teaching the client how to use "A" (Activate Movement) as an acute tool (e.g., a 15-minute walk) specifically after a high-carb meal to blunt the glucose excursion.</li>
        </ul>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: The "Perfect" Plateau</p>
                    <p style="color: white; font-size: 13px; margin: 0;">Client: Sarah, 54 | Condition: T2D & Hashimoto's</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">S</div>
                    <div class="patient-info">
                        <h4>Sarah (Initial Presentation)</h4>
                        <p>A1c: 7.2% | TSH: 4.8 | Fasting Glucose: 128 mg/dL | Weight: 185 lbs</p>
                    </div>
                </div>
                <p><strong>The Challenge:</strong> Sarah followed a strict low-carb diet and walked 10k steps daily. After 3 months, her A1c dropped to 6.4% but then stayed there for 6 months despite further calorie cutting.</p>
                <p><strong>The Synthesis:</strong> Analysis of her S.T.A.B.L.E. pillars revealed Sarah was over-exercising (A) in a hypothyroid state (B), driving up evening cortisol. This caused "Nighttime Gluconeogenesis."</p>
                <p><strong>The Customization:</strong> We reduced her walking to 7k steps, added 2 days of heavy resistance training (to increase GLUT4), and introduced a "Lifestyle Reset" (L) of 10 minutes of box breathing before bed. We also added 200mcg of Selenium to support T4 to T3 conversion.</p>
                <p><strong>Outcome:</strong> 3 months later, Sarahâ€™s A1c hit 5.6%. Her liver was finally able to "rest" at night because her cortisol was managed.</p>
            </div>
        </div>

        <h2 id="section4">4. Clinical Decision-Making & Referrals</h2>
        <p>As an expert coach, knowing when to <i>not</i> coach is as important as knowing how to coach. You are a specialist in <span class="highlight">lifestyle-driven metabolic repair</span>, but you must work in tandem with the medical team when pathology exceeds the scope of coaching.</p>

        <h3>When to Refer Out Immediately:</h3>
        <ul>
            <li><strong>Unexplained Rapid Weight Loss:</strong> Could indicate Type 1.5 (LADA) or underlying malignancy.</li>
            <li><strong>Recurrent Hypoglycemia:</strong> If a client on insulin or sulfonylureas is hitting < 70 mg/dL frequently, their medication <i>must</i> be adjusted by their physician before you continue lifestyle changes.</li>
            <li><strong>eGFR < 60:</strong> Signs of Stage 3 Chronic Kidney Disease require a renal-specific diet that may contradict standard high-protein S.T.A.B.L.E. protocols.</li>
        </ul>

        <div class="alert-box info">
            <p class="alert-label">Pro-Tip: The "Physician Bridge"</p>
            <p>When communicating with a clientâ€™s doctor, use the "Data-First" approach. Instead of saying "Sarah is doing great," send a 1-page summary: <i>"Client Sarah has reduced CGM Standard Deviation from 35 to 18 mg/dL and HOMA-IR from 4.2 to 2.1. Requesting a review of Metformin dosage to prevent nocturnal hypoglycemia."</i> This establishes you as a professional peer.</p>
        </div>

        <h2 id="section5">5. The Advanced Coach's Toolkit: CGM Analytics</h2>
        <p>In this final deep dive, we move beyond "Average Glucose" into <span class="highlight">Glycemic Variability (GV)</span>. High variabilityâ€”the "rollercoaster" effectâ€”is more predictive of cardiovascular complications than HbA1c alone.</p>

        <p>Your "Toolkit" should now include the following metrics for client reporting:</p>
        <ol>
            <li><strong>Time in Range (TIR):</strong> Aim for > 85% in the 70â€“140 mg/dL range.</li>
            <li><strong>Standard Deviation (SD):</strong> A measure of GV. The goal is an SD < 30 mg/dL. If SD is high, focus on the "T" (Nutrition) pillarâ€”specifically fiber matrix and protein leverage.</li>
            <li><strong>Glucose Management Indicator (GMI):</strong> A "predicted A1c" based on the last 14 days of CGM data. Use this to provide real-time encouragement before the official lab work.</li>
        </ol>

        <div class="stat-highlight">
            A 2022 study in <i>Diabetes Care</i> found that for every 10% increase in Time in Range (TIR), the risk of developing retinopathy decreased by 64% and microalbuminuria (kidney damage) by 40%.
        </div>

        <h2 id="section6">6. Capstone Synthesis: The S.T.A.B.L.E. Final Protocol</h2>
        <p>To finalize your mastery, remember that the S.T.A.B.L.E. Methodâ„¢ is a <span class="highlight">dynamic feedback loop</span>, not a linear checklist. As the client's biology changes, the protocol must evolve.</p>

        <div class="principle-card">
            <div class="principle-title">The "Reverse-Engineering" Logic</div>
            <p class="principle-text">If the goal is an A1c < 5.7%, we must reverse-engineer the daily environment:</p>
            <ul>
                <li><strong>S:</strong> Quarterly labs (HbA1c, Fasting Insulin, Lipid NMR).</li>
                <li><strong>T:</strong> Macronutrient ratios adjusted for physical activity levels of that specific day.</li>
                <li><strong>A:</strong> Daily movement "snacks" (10 mins) + 3x weekly "Glucose Sink" sessions (Strength).</li>
                <li><strong>B:</strong> Micronutrient support for the thyroid-adrenal-pancreas axis.</li>
                <li><strong>L:</strong> 7-9 hours of sleep with a consistent circadian anchor.</li>
                <li><strong>E:</strong> Monthly "Metabolic Check-ins" to adjust for life stressors.</li>
            </ul>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your synthesis of the S.T.A.B.L.E. Methodâ„¢</p>
            
            <div class="question-item">
                <span class="question-number">1</span>
                <p class="question-text">A client with T2D and NAFLD has a "perfect" diet but high fasting glucose. Their ALT is 45 and AST is 38. Which S.T.A.B.L.E. pillar should you prioritize first to break the plateau?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    Prioritize the <strong>B (Balance)</strong> and <strong>T (Transform)</strong> pillars specifically for the liver. High ALT/AST suggests hepatic congestion. Use Choline, NAC, or Milk Thistle (B) and increase cruciferous vegetables (T) to support the liver's ability to process lipids and regulate gluconeogenesis.
                </div>
            </div>

            <div class="question-item">
                <span class="question-number">2</span>
                <p class="question-text">Why is Glycemic Variability (Standard Deviation) often a more important metric than HbA1c for long-term health?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    HbA1c is only a 3-month average; it can hide dangerous "peaks and valleys." High Glycemic Variability (spikes and crashes) causes more oxidative stress and endothelial damage (the "Polyol Pathway" and "AGEs" discussed in Module 9) than a steady, slightly elevated blood sugar.
                </div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Lesson Takeaways</p>
            <ul>
                <li><strong>Complexity is the Norm:</strong> Always screen for the T2D-NAFLD-Thyroid triad in non-responders.</li>
                <li><strong>Troubleshoot the Liver:</strong> If fasting glucose is high despite low-carb intake, the liver is overproducing sugar; focus on cortisol and hepatic health.</li>
                <li><strong>Maintenance is Active:</strong> Transition clients to the "E" pillar by building metabolic flexibility and self-correction algorithms.</li>
                <li><strong>Professionalism via Data:</strong> Use CGM analytics (TIR, SD, GMI) to communicate effectively with medical providers.</li>
                <li><strong>Scope of Practice:</strong> Refer out for rapid weight loss, chronic hypoglycemia, or Stage 3+ CKD.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Younossi, Z. M., et al. (2021). "The global epidemiology of non-alcoholic fatty liver disease." <i>The Lancet Gastroenterology & Hepatology.</i></li>
                <li>Battelino, T., et al. (2022). "Clinical Targets for Continuous Glucose Monitoring Data Interpretation." <i>Diabetes Care.</i></li>
                <li>Biondi, B., & Cooper, D. S. (2023). "Subclinical Hyperthyroidism and Hypothyroidism: A Review." <i>JAMA.</i></li>
                <li>Frontiers in Endocrinology (2022). "The Interplay Between Cortisol and Hepatic Gluconeogenesis in Type 2 Diabetes."</li>
                <li>American Diabetes Association (2024). "Standards of Care in Diabetesâ€”2024." <i>Diabetes Care Journal.</i></li>
                <li>Smith, G. I., et al. (2023). "Insulin Resistance in NAFLD: The Role of Mitochondrial Dysfunction." <i>Cell Metabolism.</i></li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy | Diabetes & Blood Sugar Coach Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. Confidential Professional Certification Material.</p>
        </footer>
    </div>
</body>

</html>